Loading company…
SeNostic develops diagnostics for neurodegenerative diseases, including Alzheimer's and Parkinson's disease.
Founded in 2014 and headquartered in Braunschweig, Germany, SeNostic develops in-vitro diagnostics for clinical trials, recombinant proteins for research, and services for drug research. In January 2016, the company raised Seed funding from High-Tech Gründerfonds. Its clients include pharmaceutical companies and research institutions.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in